Recruiting

A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

J1G-MC-LAKB - ClinicalTrials.gov - NCT04451408

The purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD.
How long will I be in the trial?
Participation could last up to about 54 weeks and may include up to 22 visits to the study center.
Email
Recruiting

A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

J1G-MC-LAKB - ClinicalTrials.gov - NCT04451408

The purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD.
How long will I be in the trial?
Participation could last up to about 54 weeks and may include up to 22 visits to the study center.
Email

Key Requirements

Age :

55-85

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

55-85

Sex

All

Participants must

Participants must have gradual and progressive changes in memory for at least 6 months

Participants must have a family member or close friend who is with the participant at least 10 hours per week and can participate in study appointments

Participants must NOT

Participants must not have other serious or unstable illnesses

Participants must not have magnetic implants or have a fear of being in an enclosed space

Participants must not have multiple or severe drug allergies

Participants must not have a serious risk for suicide

Participants must not drink alcohol heavily or abuse street drugs

Trial Summary

Conditions the trial is for

Mild Cognitive Impairment, Mild Alzheimer's, Moderate Alzheimer's, Early Symptoms of Alzheimer's Disease

What the trial is testing?

LY3372993

Could I receive a Placebo?

yes

Enrollment Goal

30

Trial Dates

July 2020 - April 2022

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

55-85

Sex

All

Participants must

Participants must have gradual and progressive changes in memory for at least 6 months

Participants must have a family member or close friend who is with the participant at least 10 hours per week and can participate in study appointments

Participants must NOT

Participants must not have other serious or unstable illnesses

Participants must not have magnetic implants or have a fear of being in an enclosed space

Participants must not have multiple or severe drug allergies

Participants must not have a serious risk for suicide

Participants must not drink alcohol heavily or abuse street drugs

Trial Summary

Conditions the trial is for

Mild Cognitive Impairment, Mild Alzheimer's, Moderate Alzheimer's, Early Symptoms of Alzheimer's Disease

What the trial is testing?

LY3372993

Could I receive a Placebo?

yes

Enrollment Goal

30

Trial Dates

July 2020 - April 2022

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Memory, Alzheimer’s Disease, and Research Studies

Memory, Alzheimer’s Disease, and Research Studies

With the help of research study participants, we are learning about aging, memory, and potential new approaches to fighting Alzheimer’s disease.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?